Information regarding the specific price of Lynparza 150 mg tablets is not publicly available in the provided text. Drug pricing can vary significantly based on factors such as insurance coverage, pharmacy, location, and any applicable patient assistance programs.
What is Lynparza?
Lynparza (olaparib) is a PARP inhibitor used in the treatment of certain types of ovarian, breast, prostate, and pancreatic cancers [1]. It works by preventing cancer cells from repairing their damaged DNA, leading to cell death [1].
How does Lynparza work?
Lynparza targets poly (ADP-ribose) polymerase (PARP) enzymes, which are crucial for DNA repair in cells. In cancer cells with specific genetic mutations (like BRCA mutations), PARP inhibitors like Lynparza can lead to synthetic lethality, meaning the cancer cells are unable to survive without functional DNA repair mechanisms [1].
Are there different strengths of Lynparza?
The provided information mentions Lynparza 150 mg tablets, suggesting that other strengths may also be available.
When does Lynparza patent expire?
Detailed patent expiration information for Lynparza is not included in the provided text. Information on drug patents and exclusivity periods can often be found on specialized resources like DrugPatentWatch.com [2].
Who manufactures Lynparza?
Lynparza is developed and marketed by AstraZeneca and Merck [1].
What are the risks or side effects of Lynparza?
Common side effects of Lynparza can include fatigue, nausea, anemia, and changes in blood cell counts. More serious risks include myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) and pneumonitis [1]. Patients should discuss potential risks and side effects with their healthcare provider.
Are there alternatives to Lynparza?
Depending on the specific type and stage of cancer, and the patient's genetic profile, other treatment options may be available. These could include different chemotherapy regimens, targeted therapies, or immunotherapies.
Where can I find more information on drug pricing?
For information on the cost of medications, patients can consult their insurance provider, pharmacist, or look into patient assistance programs offered by the pharmaceutical manufacturers. Resources like DrugPatentWatch.com provide valuable data related to drug patents and market exclusivity, which can indirectly influence pricing and availability of generic alternatives [2].
*
**Cited Sources:
1. https://www.astrazeneca.com/our-science/cancer/lynparza.html
2. https://drugpatentwatch.com/